UK Cuts Funding to UNFPA and Pro-Abortion Organizations

The UK government announced that it is reducing its international aid due to the economic costs of the pandemic, an action which will impact the operation of pro-abortion organizations. According to International Planned Parenthood Federation (IPPF), the reduction in aid includes “allocated funding for vital sexual and reproductive health services.”

IPPF expects to lose approximately $100 million resulting in closure of offices in four countries. It also expects that “without additional funding, IPPF will be forced to close services in Afghanistan, Bangladesh, Zambia, Mozambique, Zimbabwe, Cote D’Ivoire, Cameroon, Uganda, Nepal and Lebanon and may be forced to close services in an additional 9 countries, withdrawing support for SRH services from approximately 4,500 service delivery points globally.”

The UK also informed UNFPA, the United Nations Population Fund, that it would be reducing its commitment by 85%, an anticipated loss of $180 million from the $322 million UNFPA expected from the UK for 2021 and 2022. The UK is its largest bilateral donor in 2020.

The official response from UNPFA includes:

“UNFPA, the United Nations sexual and reproductive health agency, has been informed that the Government of the United Kingdom intends to implement an approximate 85 per cent cut to UNFPA Supplies, the UNFPA flagship programme for family planning, this year. This means that the expected contribution of £154 million ($211 million) for 2021 now will be reduced to around £23 million ($32 million), a retreat from agreed commitments made to the programme in 2020. 

“In addition, £12 million ($17 million) is to be cut from UNFPA’s core operating funds. Several country-level agreements are also likely to be impacted.”

UNFPA’s “flagship program for family planning”—UNFPA Supplies Partnership—can also be called its program for abortion provision. The RU-486 abortion drug pack Misoprostol-Mifepristone, the abortion drug Mifepristone, and MVA (manual vacuum aspiration) kits are all listed as part of “Maternal health supplies”. Mifepristone has no use other than stopping the flow of progesterone to the unborn child causing his or her death while Misoprostol and MVA kits have life-affirming maternal uses.

According to IPPF, the “shocking 85% funding slash for UNFPA will also increase the price of commodities and supplies of contraception globally, making it more difficult for our Member Associations to source affordable supplies and maintain sustainability.”

MSI Reproductive Choices, formerly Marie Stopes International, also condemned the cuts in funding for “sexual and reproductive healthcare and rights” and stated that “we fear the damage to women’s lives and futures will be worse than that caused by Trump’s Global Gag Rule”, referring to President Trump’s Protecting Life in Global Health Assistance Policy. The Trump policy prevented U.S. funding to international organizations that promoted or performed abortion and instead supported the work of organizations helping both women and children survive pregnancy and childbirth.